Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

December 27, 2019 00:23:35
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?
Critical Care Perspectives in Emergency Medicine
Benzodiazepine-Refractory Status Epilepticus - Which Drug is Second-Line?

Dec 27 2019 | 00:23:35

/

Show Notes

Up to one-third of patients with status epilepticus will not respond to benzodiazepines.  Unfortunately, treatment of benzodiazepine-refractory status epilepticus is not well studied.  The longer seizures persist, the worse patients do.  In this podcast, we discuss the results of the recently completed ESETT trial that evaluated three anticonvulsant medications for status epilepticus.

You can get CME credit for this episode here!Click here for CME Account Creation Instructions

Other Episodes

Episode

February 06, 2018 00:22:23
Episode Cover

Reversal Strategies for Life-threatening Bleeding due to DOACs!

He's back!  Bryan Hayes joins the podcast to discuss the latest evidence pertaining to the reversal of life-threatening hemorrhage secondary to the direct oral...

Listen

Episode 0

March 09, 2017 00:30:38
Episode Cover

Family Centered Care in the Critically Ill

New guidelines have just been published on the care of family members of critically ill patients! So many family members of critically ill patients...

Listen

Episode

June 07, 2024 00:22:24
Episode Cover

Cefepime vs. Piperacillin-Tazobactam for Infection?  The ACORN Trial

Timely and appropriate administration of empiric broad-spectrum antibiotics for adult patients with sepsis is critical.  Current guidelines recommend an antipseudomonal antibiotic for those at...

Listen